Skip to main content

Diagnostic options · UAE

Neurogenetics tests in Dubai & UAE

Compare available Neurogenetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

68

Listed price range

-1.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurogenetics test prices

Showing 61–68 of 68 matching tests.

Neurogenetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-4855
TECR Gene Sequencing (Intellectual Disability, Autosomal Recessive Type 14) Test

This test identifies pathogenic variants in the TECR gene associated with autosomal recessive intellectual disability type 14.

Whole blood, extracted DNA, or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TECR gene", "Coverage of coding regions"]
Parameters
[]
Preparation
["Provide detailed clinical history", "Provide developmental milestones", "Provide family pedigree", "Genetic counselling session required"]
Indications
["Suspected autosomal recessive intellectual disability type 14", "Family history of neurodevelopmental disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96669-4 ICD-10: F79, Q02, Z15.89
Clinical summary
This test identifies pathogenic variants in the TECR gene associated with autosomal recessive intellectual disability type 14.
TEST-5767
TMEM240 Gene Spinocerebellar Ataxia Type 21, Autosomal Dominant Genetic Test

This test identifies pathogenic variants in the TMEM240 gene, the cause of autosomal dominant spinocerebellar ataxia type 21.

Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TMEM240 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"]
Parameters
[{"name": "Variant Allele Frequency", "reference_range": "Down to 5%"}]
Preparation
["No fasting required", "No special preparation needed"]
Indications
["Confirmation of clinical diagnosis of SCA21", "Presymptomatic testing for at-risk individuals", "Family planning and genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: G11.2
Clinical summary
This test identifies pathogenic variants in the TMEM240 gene, the cause of autosomal dominant spinocerebellar ataxia type 21.
TEST-5334
TUBB Gene Neurodevelopmental Disorder NGS Test

This test evaluates the TUBB gene for variants associated with neurodevelopmental disorders and brain malformations.

Whole Blood (peripheral) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs) in the TUBB gene"]
Parameters
[]
Preparation
["Pre-test genetic counseling is mandatory", "Informed consent required"]
Indications
["Individuals with unexplained intellectual disability", "Individuals with cortical dysplasia", "Individuals with epilepsy", "Individuals with lissencephaly spectrum"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92738-5 ICD-10: Q04.8, F70, G40.909
Clinical summary
This test evaluates the TUBB gene for variants associated with neurodevelopmental disorders and brain malformations.
TEST-5815
TWNK Gene Infantile-Onset Spinocerebellar Ataxia (SCA) Genetic Test

This genetic test identifies pathogenic variants within the TWNK gene associated with infantile-onset spinocerebellar ataxia.

Peripheral Whole Blood (1-2 mL) or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TWNK gene", "Mitochondrial DNA replication defects"]
Parameters
[]
Preparation
["Informed consent and a three-generation pedigree are mandatory prior to sample collection.", "Do not discontinue or alter prescribed medications without consulting the treating physician."]
Indications
["Infants presenting with symptoms suggestive of infantile-onset spinocerebellar ataxia", "Family history of mitochondrial disorders", "Need for definitive molecular diagnosis for clinical management and genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94217-3 ICD-10: G11.0
Clinical summary
This genetic test identifies pathogenic variants within the TWNK gene associated with infantile-onset spinocerebellar ataxia.
TEST-5404
WDR45 Gene Neurodegeneration with Brain Iron Accumulation Type 5 (BPAN) Genetic Test

This test identifies pathogenic variants in the WDR45 gene associated with Beta-Propeller Protein-Associated Neurodegeneration (BPAN), also known as Neurodegeneration with Brain Ir...

Whole Blood (EDTA), Extracted DNA, FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WDR45 gene", "Single-Nucleotide Variants (SNVs)", "Indels", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "Mandatory genetic counselling session prior to collection"]
Indications
["Suspicion of NBIA-spectrum disorder", "Developmental regression", "Movement disorders", "Characteristic brain MRI patterns"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82307-8 ICD-10: G23.0
Clinical summary
This test identifies pathogenic variants in the WDR45 gene associated with Beta-Propeller Protein-Associated Neurodegeneration (BPAN), also known as Neurodegeneration with Brain Iron Accumulation Type 5 (NBIA5).
TEST-4016
WDR81 Gene Cerebellar Ataxia, Intellectual Disability, and Dysequilibrium Syndrome Type 2 (CAMRQ2) Genetic Test

This genetic test identifies pathogenic variants within the WDR81 gene associated with Cerebellar Ataxia, Intellectual Disability, and Dysequilibrium Syndrome Type 2 (CAMRQ2).

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WDR81 gene coding region variants", "Pathogenic mutations"]
Parameters
[]
Preparation
["No fasting required", "Ensure patient is comfortable and well-hydrated"]
Indications
["Suspected CAMRQ2 syndrome", "Family history of CAMRQ2", "Neurological symptoms consistent with CAMRQ2"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: G11.1, F70
Clinical summary
This genetic test identifies pathogenic variants within the WDR81 gene associated with Cerebellar Ataxia, Intellectual Disability, and Dysequilibrium Syndrome Type 2 (CAMRQ2).
TEST-4315
WWOX Gene NGS Test for Early Infantile Epileptic Encephalopathy Type 28 (EIEE28)

This test identifies pathogenic variants in the WWOX gene associated with early infantile epileptic encephalopathy type 28 (EIEE28). It provides a definitive molecular diagnosis fo...

Peripheral whole blood (EDTA) or dried blood spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WWOX gene", "Single-nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Confirmation of suspected EIEE28", "Genetic diagnosis in infants with specific neurological symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81329-4 ICD-10: G40.4
Clinical summary
This test identifies pathogenic variants in the WWOX gene associated with early infantile epileptic encephalopathy type 28 (EIEE28). It provides a definitive molecular diagnosis for this severe neurogenetic disorder.
TEST-5001
ZDHHC9 Gene Sequencing (Mental Retardation, X‑Linked Syndromic, Raymond Type) Genetic Test

This test evaluates the ZDHHC9 gene for pathogenic variants associated with X-linked syndromic mental retardation (Raymond type).

Whole Blood (EDTA) or Extracted DNA 10–14 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZDHHC9 gene", "Copy Number Variations (CNV) in the ZDHHC9 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist about anticoagulant therapy"]
Indications
["Suspected X-linked syndromic mental retardation (Raymond type)", "Family history of ZDHHC9-related disorders", "Genetic counselling for reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21624-7 ICD-10: F79
Clinical summary
This test evaluates the ZDHHC9 gene for pathogenic variants associated with X-linked syndromic mental retardation (Raymond type).

Category overview

Neurogenetics: overview

Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurogenetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurogenetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.